CClinicalTrials.gg
CompletedNCT00504036BIGPOMUpdated Nov 1, 2011

Efficacy of Preoperative Intra Gastric Balloon in Morbidly Obese Patients Selected for Gastric By-pass

An interventional study of inflatable intra-gastric balloon in Morbid Obesity, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2011-11-01.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
314
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

To demonstrate, during a prospective randomized medico-economic study, in morbidly obese patients (BMI > 45 kg/m²) selected for a laparoscopic gastric by-pass that, in comparison to usual care, a temporary intra-gastric balloon (6 months) decreases medical costs and peri-operative morbidity.

Read the detailed description

On inclusion, comorbidities associated with obesity will be recorded. After recording of the informed consent patients will be randomized in two groups: usual care or intra-gastric balloon. In the latter, a second randomization will be performed between air-filled balloon or water-filled balloon. Six months later, after withdrawal of the balloon (if required), laparoscopic gastric by-pass will be performed. Thereafter, patients will be followed during 6 months.

On each visit, inclusion, 3 months, 6 months, surgery, 1 month and 6 months post surgery, a medical and biological evaluation will be systematically performed.

The main criteria of judgement is the rate of admission in ICU during more than 24 hrs during the 30 days following surgery.

The secondary criteria of judgement is: the differences in pre-operative weight loss between the 2 groups, number of complications occurring during the 30 days after surgery, differences in different scales of quality of life (SF36, IWQOL-lite), differences in operative time, length of hospital stay, readmissions, and medical cots between the two strategies. Efficacy and tolerance of each type of balloon (air-filled or water-filled) will be compared in the intra-gastric balloon group.

02

Conditions studied

  • Morbid Obesity

Keywords

  • Obesity
  • Morbid obesity
  • Gastric balloon
  • Gastric by-pass
  • Morbid obesity with BMI > 45 kg/m²
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 314 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 75 years
  • Patients with morbid obesity with BMI > 45 kg/m² requiring a gastric by-pass by laparoscopy.
  • No efficacy of previous treatment on obesity
  • Firmed informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients in whom laparoscopy is contra-indicated
  • Indication of gastric by-pass by laparoscopy retained without multidisciplinary advice
  • Morbid obesity present since less than 5 years
  • Severe associated pathology, non-related to obesity, impairing vital prognosis on a short or mean time
  • Past history of gastric surgery, or gastric complication related to gastric lap-band
  • Lack of health insurance
  • Patient refusing to be followed 6 months before and after surgery
  • Drug abuse
  • Pregnancy or foreseeable pregnancy during the study
  • Patients taking anticoagulant agents or steroids
  • Patients with hiatal hernia > 4 cm
  • Patients with active ulcerated esophagitis (grade C-D in Los Angeles Classification)
  • Patients with duodenal or gastric ulcer
  • Patients with gastric or esophageal varices
  • Patients with NSAIDs not taking PPI
  • Patients with bulimia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
314 participants (actual)

Study arms

  • Experimental
    Intra-gastric balloon

    Patients will receive either an air-filled or water-filled intra-gastric balloon.

    Device: inflatable intra-gastric balloon

  • No intervention
    Usual care

    Usual care will be given to the patients.

Interventions

  • Deviceinflatable intra-gastric balloon

    inflatable intra-gastric balloon

06

What researchers measure

Primary outcomes

  1. Rate of admission in Intensive Care Units

    Time frame: > 24 hrs during the 30-day period following gastric by-pass

Secondary outcomes

  1. Differences in absolute weight loss

    Time frame: at 6 months, before gastric by-pass, between the 2 strategies

  2. Number and types of complications occurring

    Time frame: during the 30-day post-operative period

  3. Number of comorbidities present

    Time frame: after the 6-month initial period

  4. Differences in quality of life

    Time frame: at the end of first 6-month period and at the end of the study

  5. Differences in time of surgery, length of stay, readmission

    Time frame: during the 30-day post by-pass period

  6. Differences in medical costs between the 2 strategies

    Time frame: 6 months before and after gastric by-pass

07

Study locations

1 site
  • Hopital Louis Mourier
    Colombes, 92700, France
08

References and documents

Publications

  • Fernandes M, Atallah AN, Soares BG, Humberto S, Guimaraes S, Matos D, Monteiro L, Richter B. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004931. doi: 10.1002/14651858.CD004931.pub2. PubMed 17253531 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00504036
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Jul 19, 2007
Start date
Oct 2007
Primary completion
Jul 2011
Completion
Jul 2011
Last update
Nov 1, 2011

Study contacts

Benoit Coffin, PU-PH
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion